Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Net Margin (2017 - 2025)

Selectis Health's Net Margin history spans 14 years, with the latest figure at 6.87% for Q3 2025.

  • For Q3 2025, Net Margin rose 2299.0% year-over-year to 6.87%; the TTM value through Sep 2025 reached 1.94%, up 1245.0%, while the annual FY2024 figure was 6.19%, 468.0% up from the prior year.
  • Net Margin for Q3 2025 was 6.87% at Selectis Health, up from 3.02% in the prior quarter.
  • Across five years, Net Margin topped out at 41.83% in Q1 2023 and bottomed at 39.56% in Q4 2023.
  • The 5-year median for Net Margin is 6.4% (2025), against an average of 6.32%.
  • The largest annual shift saw Net Margin skyrocketed 3956bps in 2023 before it tumbled -5281bps in 2024.
  • A 5-year view of Net Margin shows it stood at 17.64% in 2021, then dropped by -15bps to 20.37% in 2022, then crashed by -94bps to 39.56% in 2023, then skyrocketed by 86bps to 5.54% in 2024, then surged by 224bps to 6.87% in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Net Margin are 6.87% (Q3 2025), 3.02% (Q2 2025), and 6.4% (Q1 2025).